Actipulse Neuroscience Analysis
What is Actipulse Neuroscience?
Actipulse Neuroscience develops non-invasive brain stimulation technologies aimed at treating psychiatric and neurological disorders through transcranial neuromodulation devices.
Employees
38
Founded
2017
Revenue
$174K-$2.9M
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
- Non-Invasive Brain Stimulation technologies, transcranial neuromodulation devices, treatment for Major Depressive Disorder, oncology applications.
Who are the founders of Actipulse Neuroscience
AC
Adrien Châtillon
Founder
GV
Gabriel Villafuerte
Founder
Company Pricing
- Treatment with Actipulse Home is anticipated to cost between $1,200 and $1,600 for a duration of approximately 3 months.
Investors
- Y Combinator
- MassChallenge
- FoundersX Ventures
- Trav Walkowski
- Empire Group International
Find more companies like Actipulse Neuroscience
See something that needs updating? Suggest edits to this profile.
